Tag: Valneva
Coronavirus-EU decision on Valneva vaccines not yet final – 2022-05-16 at 12:30
BRUSSELS, May 16 (Reuters) – The European Commission said on Monday it had not yet taken a final decision on whether to cancel the contract for COVID-19 vaccines with French…
Valneva: possible termination of the Covid contract by Brussels
(CercleFinance.com) – Valneva announces that it has received from the European Commission a notice of intent to terminate the supply agreement for its candidate vaccine against Covid-19, VLA2001, as it…
Anti-Covid vaccine Valneva: “notice of intention to terminate” the contract by the European Commission
The Franco-Austrian pharmaceutical group Valneva has received from the European Commission “a notice of intent to terminate the supply agreement” for its vaccine against Covid-19 (AFP/Archives/JEAN-FRANCOIS MONIER) The Franco-Austrian pharmaceutical…
Valneva: authorization of the Covid vaccine in the Emirates
(CercleFinance.com) – Valneva announces that the United Arab Emirates has granted an authorization for the emergency use of its inactivated and adjuvanted vaccine against Covid-19, VLA2001, its second authorization in…
Valneva, European ambitions
Subscribe for 1€ Unlimited access to all advice More than 800 stocks listed in Paris and abroad screened. To buy ? To sell ? What course objective? Our experts engage…
Analyst recommendations: Euroapi, Solutions 30, Valneva, Scor, Vicat, JCDecaux, Air France-KLM
Three changes in recommendation this morning, on Euroapi, Solutions 30 and Valneva shares. Some price adjustments, generally downwards, are also worth noting. Analyst recommendations: Euroapi, Solutions 30, Valneva, Scor, Vicat,…
Valneva well oriented after its quarterly results – 05/05/2022 at 16:01
(AOF) – Valneva gained more than 4% to 12.35 euros after the publication of a stable quarterly turnover and the confirmation of its annual objectives. Over the first three months…
Valneva: evaluation trial of its Covid vaccine
(CercleFinance.com) – Valneva today announced the initiation of a clinical trial to evaluate its inactivated whole virus COVID-19 vaccine candidate, VLA2001, as a heterologous booster. This will be the first…
Valneva: modifies the financing agreement concluded with the Deerfield and OrbiMed funds
By Alexandra Saintpierre Published on 04/26/2022 at 4:28 p.m. Photo credit © Valneva …
Valneva increases the amount of a financing agreement, the action climbs
(Update: stock market reaction) PARIS (Agefi-Dow Jones)–The biotechnology company Valneva announced on Tuesday that it has signed an agreement allowing it to increase by $40 million the principal amount of…
Valneva and Pfizer publish pediatric data for their Lyme disease vaccine – 04/26/2022 at 07:07
April 26 (Reuters) – Valneva Se VLS.PA and Pfizer PFE.N said in a statement on Tuesday: * POSITIVE PHASE 2 PEDIATRIC DATA FOR THEIR LYME DISEASE VACCINE CANDIDATE * REPORT…
Valneva increases the amount of its financing agreement with two American funds
PARIS (Agefi-Dow Jones)–The biotechnology company Valneva announced on Tuesday that it has signed an agreement allowing it to increase by $40 million the principal amount of its existing financing agreement…